Ivermectin cost insurers $130M in one year during the pandemic

Insurers paid for anti-parasite drug as a treatment for COVID-19 despite lack of evidence surrounding its effectiveness, according to a new study.


You may also like

Brent crude oil

Brent crude oil

Crude oil

Crude oil